Systematic review and meta-analysis of the association between complementary factor H Y402H polymorphisms and age-related macular degeneration

Human Molecular Genetics

Volumn 15, Issue 18, 2006, Pages 2784-2790

  Thakkinstian, Ammarin ^a,b   Han, Pearline ^a   McEvoy, Mark ^a   Smith, Wayne ^a   Hoh, Josephine ^c   Magnusson, Kristinn ^d   Zhang, Kang ^e   Attia, John ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b MAHIDOL UNIVERSITY   (Thailand)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DECODE GENETICS   (Iceland)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; COMPLEMENT FACTOR H; HISTIDINE; TYROSINE;

ALLELE; ALZHEIMER DISEASE; ATTRIBUTABLE RISK; BLINDNESS; DATA EXTRACTION; DEVELOPED COUNTRY; DISEASE ASSOCIATION; GENETIC MODEL; GENOTYPE; HUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PUBLICATION; QUALITY CONTROL; RETINA MACULA DEGENERATION; REVIEW; SYSTEMATIC REVIEW;

AGED; AGED, 80 AND OVER; ALLELES; AMINO ACID SUBSTITUTION; COMPLEMENT FACTOR H; FEMALE; GENE FREQUENCY; HUMANS; MACULAR DEGENERATION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33748752137     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl220     Document Type: Review

References (60)

1. Mitchell, P., Smith, W., Attebo, K. and Wang, J.J. (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology, 102, 1450-1460.
2. VanNewkirk, M.R., Nanjan, M.B., Wang, J.J., Mitchell, P., Taylor, H.R. and McCarty, C.A. (2000) The prevalence of age-related maculopathy: The visual impairment project. Ophthalmology, 107, 1593-1600.
3. Pang, C.P. and Lam, D.S. (2002) Differential occurrence of mutations causative of eye diseases in the Chinese population. Hum. Mutat., 19, 189-208.
4. Klein, M.L., Schultz, D.W., Edwards, A., Matise, T.C., Rust, K., Berselli, C.B., Trzupek, K., Weleber, R.G., Ott, J., Wirtz, M.K. et al. (1998) Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch. Ophthalmol., 116, 1082-1088.
5. Evans, J. and Wormald, R. (1996) Is the incidence of registrable age-related macular degeneration increasing? Br. J. Ophthalmol., 80, 9-14.
6. Klein, R., Klein, B. and Linton, K. (1992) Prevalence of age-related maculopathy: The Beaver Dam Eye study. Ophthalmology, 99, 933-943.
7. Schmidt, S., Klaver, C., Saunders, A., Postel, E., De La Paz, M., Agarwal, A., Small, K., Udar, N., Ong, J., Chalukya, M. et al. (2002) A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic. Genet., 23, 209-223.
8. Vingerling, J.R., Dielemans, I., Hofman, A., Grobbee, D.E., Hijmering, M., Kramer, C.F. and de Jong, P.T. (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology, 102, 205-210.
9. Tomany, S.C., Wang, J.J., Van Leeuwen, R., Klein, R., Mitchell, P., Vingerling, J.R., Klein, B.E., Smith, W. and De Jong, P.T. (2004) Risk factors for incident age-related macular degeneration: Pooled findings from 3 continents. Ophthalmology, 111, 1280-1287.
10. Seddon, J., Ajani, U. and Mitchell, B. (1997) Familial aggregation of age-related maculophaty. Am. J. Ophthalmol., 123, 199-206.
11. Klein, M.L., Mauldin, W.M. and Stoumbos, V.D. (1994) Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch. Ophthalmol., 112, 932-937.
12. Klaver, C.C., Wolfs, R.C., Assink, J.J., van Duijn, C.M., Hofman, A. and de Jong, P.T. (1998) Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch. Ophthalmol., 116, 1646-1651.
13. Silvestri, G., Johnston, P.B. and Hughes, A.E. (1994) Is genetic predisposition an important risk factor in age-related macular degeneration? Eye, 8 (Pt 5), 564-568.
14. Heiba, I.M., Elston, R.C., Klein, B.E. and Klein, R. (1994) Sibling correlations and segregation analysis of age-related maculopathy: The Beaver Dam Eye Study. Genet. Epidemiol., 11, 51-67.
15. Yates, J.R. and Moore, A.T. (2000) Genetic susceptibility to age related macular degeneration. J. Med. Genet., 37, 83-87.
16. Meyers, S.M., Greene, T. and Gutman, F.A. (1995) A twin study of age-related macular degeneration. Am. J. Ophthalmol., 120, 757-766.
17. Hammond, C.J., Webster, A.R., Snieder, H., Bird, A.C., Gilbert, C.E. and Spector, T.D. (2002) Genetic influence on early age-related maculopathy: a twin study. Ophthalmology, 109, 730-736.
18. Weeks, D.E., Conley, Y.P., Tsai, H.J., Mah, T.S., Rosenfeld, P.J., Paul, T.O., Eller, A.W., Morse, L.S., Dailey, J.P., Ferrell, R.E. et al. (2001) Age-related maculopathy: An expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Am. J. Ophthalmol., 132, 682-692.
19. Weeks, D.E., Conley, Y.P., Tsai, H.J., Mah, T.S., Schmidt, S., Postel, E.A., Agarwal, A., Haines, J.L., Pericak-Vance, M.A., Rosenfeld, P.J. et al. (2004) Age-related maculopathy: A genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am. J. Hum. Genet., 75, 174-189.
20. Majewski, J., Schultz, D.W., Weleber, R.G., Schain, M.B., Edwards, A.O., Matise, T.C., Acott, T.S., Ott, J. and Klein, M.L. (2003) Age-related macular degeneration - a genome scan in extended families. Am. J. Hum. Genet., 73, 540-550.
21. Schick, J.H., Iyengar, S.K., Klein, B.E., Klein, R., Reading, K., Liptak, R., Millard, C., Lee, K.E., Tomany, S.C., Moore, E.L. et al. (2003) A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. Am. J. Hum. Genet., 72, 1412-1424.
22. Seddon, J.M., Santangelo, S.L., Book, K., Chong, S. and Cote, J. (2003) A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am. J. Hum. Genet., 73, 780-790.
23. Abecasis, G.R., Yashar, B.M., Zhao, Y., Ghiasvand, N.M., Zareparsi, S., Branham, K.E., Reddick, A.C., Trager, E.H., Yoshida, S., Bahling, J. et al. (2004) Age-related macular degeneration: A high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am. J. Hum. Genet., 74, 482-494.
24. Fisher, S.A., Abecasis, G.R., Yashar, B.M., Zareparsi, S., Swaroop, A., Iyengar, S.K., Klein, B.E., Klein, R., Lee, K.E., Majewski, J. et al. (2005) Meta-analysis of genome scans of age-related macular degeneration. Hum. Mol. Genet., 14, 2257-2264.
25. Gorin, M.B., Breitner, J.C., De Jong, P.T., Hageman, G.S., Klaver, C.C., Kuehn, M.H. and Seddon, J.M. (1999) The genetics of age-related macular degeneration. Mol. Vis., 5, 29.
26. Schultz, D.W., Klein, M.L., Humpert, A., Majewski, J., Schain, M., Weleber, R.G., Ott, J. and Acott, T.S. (2003) Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch. Ophthalmol., 121, 679-683.
27. Iyengar, S.K., Song, D., Klein, B.E., Klein, R., Schick, J.H., Humphrey, J., Millard, C., Liptak, R., Russo, K., Jun, G. et al. (2004) Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am. J. Hum. Genet., 74, 20-39.
28. Donoso, L.A., Kim, D., Frost, A., Callahan, A. and Hageman, G. (2006) The role of inflammation in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol., 51, 137-152.
29. Rodriguez de Cordoba, S., Esparza-Gordillo, J., Goicoechea de Jorge, E., Lopez-Trascasa, M. and Sanchez-Corral, P. (2004) The human complement factor H: Functional roles, genetic variations and disease associations. Mol. Immunol., 41, 355-367.
30. Haines, J.L., Hauser, M.A., Schmidt, S., Scott, W.K., Olson, L.M., Gallins, P., Spencer, K.L., Kwan, S.Y., Noureddine, M., Gilbert, J.R. et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science, 308, 419-421.
31. Seddon, J.M., Gensler, G., Milton, R.C., Klein, M.L. and Rifai, N. (2004) Association between C-reactive protein and age-related macular degeneration. JAMA, 291, 704-710.
32. Johnson, L.V., Leitner, W.P., Staples, M.K. and Anderson, D.H. (2001) Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp. Eye Res., 73, 887-896.
33. Mullins, R.F., Russell, S.R., Anderson, D.H. and Hageman, G.S. (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J., 14, 835-846.
34. Sivaprasad, S. and Chong, N.V. (2006) The complement system and age-related macular degeneration. Eye, 20, 867-872.
35. Thakkinstian, A., D'Este, C., Eisman, J., Nguyen, T. and Attia, J. (2004) Meta-analysis of molecular association studies: Vitamin D receptor gene polymorphisms and BMD as a case study. J. Bone Miner. Res., 19, 419-428.
36. Thakkinstian, A., McElduff, P., D'Este, C., Duffy, D. and Attia, J. (2005) A method for meta-analysis of molecular association studies. Stat. Med., 24, 1291-1306.
37. Conley, Y.P., Thalamuthu, A., Jakobsdottir, J., Weeks, D.E., Mah, T., Ferrell, R.E. and Gorin, M.B. (2005) Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum. Mol. Genet., 14, 1991-2002.
38. Edwards, A.O., Ritter, R., III., Abel, K.J., Manning, A., Panhuysen, C. and Farrer, L.A. (2005) Complement factor H polymorphism and age-related macular degeneration. Science, 308, 421-424.
39. Hageman, G.S., Anderson, D.H., Johnson, L.V., Hancox, L.S., Taiber, A.J., Hardisty, L.I., Hageman, J.L., Stockman, H.A., Borchardt, J.D., Gehrs, K.M. et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl Acad. Sci. USA, 102, 7227-7232.
40. Klein, R.J., Zeiss, C., Chew, E.Y., Tsai, J.Y., Sackler, R.S., Haynes, C., Henning, A.K., SanGiovanni, J.P., Mane, S.M., Mayne, S.T. et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science, 308, 385-389.
41. Magnusson, K.P., Duan, S., Sigurdsson, H., Petursson, H., Yang, Z., Zhao, Y., Bernstein, P.S., Ge, J., Jonasson, F., Stefansson, E. et al. (2006) CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med., 3, e5.
42. Souied, E.H., Leveziel, N., Richard, F., Dragon-Durey, M.A., Coscas, G., Soubrane, G., Benlian, P. and Fremeaux-Bacchi, V. (2005) Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol. Vis., 11, 1135-1140.
43. Zareparsi, S., Branham, K.E., Li, M., Shah, S., Klein, R.J., Ott, J., Hoh, J., Abecasis, G.R. and Swaroop, A. (2005) Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am. J. Hum. Genet., 77, 149-153.
44. Rivera, A., Fisher, S.A., Fritsche, L.G., Keilhauer, C.N., Lichtner, P., Meitinger, T. and Weber, B.H. (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum. Mol. Genet., 14, 3227-3236.
45. Sepp, T., Khan, J.C., Thurlby, D.A., Shahid, H., Clayton, D.G., Moore, A.T., Bird, A.C. and Yates, J.R. (2006) Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest. Ophthalmol. Vis. Sci., 47, 536-540.
46. Minelli, C., Thompson, J.R., Abrams, K.R., Thakkinstian, A. and Attia, J. (2005) The choice of a genetic model in the meta-analysis of molecular association studies. Int. J. Epidemiol., 34, 1319-1328.
47. Despriet, D.D., Klaver, C.C., Witteman, J.C., Bergen, A.A., Kardys, I., de Maat, M.P., Boekhoorn, S.S., Vingerling, J.R., Hofman, A., Oostra, B.A. et al. (2006) Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA, 296, 301-309.
48. Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., Myers, R.H., Pericak-Vance, M.A., Risch, N. and van Duijn, C.M. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 278, 1349-1356.
49. Thakkinstian, A., McEvoy, M., Minelli, C., Gibson, P., Hancox, B., Duffy, D., Thompson, J., Hall, I., Kaufman, J., Leung, T.F. et al. (2005) Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: A HuGE review. Am. J. Epidemiol., 162, 201-211.
50. Thompson, S.G. (1994) Why sources of heterogeneity in meta-analysis should be investigated. BMJ, 309, 1351-1355.
51. Thompson, S.G., Smith, T.C. and Sharp, S.J. (1997) Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat. Med., 16, 2741-2758.
52. Thompson, S.G. and Sharp, S.J. (1999) Explaining heterogeneity in meta-analysis: A comparison of methods. Stat. Med., 18, 2693-2708.
53. Trikalinos, T.A., Salanti, G., Khoury, M.J. and Ioannidis, J.P. (2006) Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am. J. Epidemiol., 163, 300-309.
54. Hernandez, J.L. and Weir, B.S. (1989) A disequilibrium coefficient approach to Hardy-Weinberg testing. Biometrics, 45, 53-70.
55. Egger, M., Davey Smith, G., Schneider, M. and Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634.
56. Egger, M., Smith, G.D. and Altman, D.G. (2001) Systematic Reviews in Health Care: Meta-analysis in Context., 2nd edn. BMJ Books, London.
57. Rossman, M.D., Thompson, B., Frederick, M., Maliarik, M., Iannuzzi, M.C., Rybicki, B.A., Pandey, J.P., Newman, L.S., Magira, E., Beznik-Cizman, B. et al. (2003) HLA-DRB1*1101: A significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet, 73, 720-735.
58. Hayden, K.M., Zandi, P.P., Lyketsos, C.G., Tschanz, J.T., Norton, M.C., Khachaturian, A.S., Pieper, C.F., Welsh-Bohmer, K.A. and Breitner, J.C. (2005) Apolipoprotein E genotype and mortality: Findings from the Cache County Study. J. Am. Geriatr. Soc, 53, 935-942.
59. StataCorp (2005) Stata Statistical Software: Release 9.0, Stata Corporation, Collage Station, TX, USA.
60. Spiegelhalter, D., Thomas, A., Best, N. and Lunn, D. (2003) WinBUGS User Manual. 1.4 edn. MRC Biostatistics Unit, UK.